22 research outputs found
COMBINED USE OF SPACE-BORNE OBSERVATIONS OF NO2 AND REGIONAL CTM MODEL FOR AIR QUALITY MONITORING IN NORTHERN ITALY
The use of space-borne measurements of trace gas constituents for air quality monitoring is considerably increased during
the past decade. This is due mainly to the new generation sensors able to observe large areas with good temporal resolution and due
to new assimilation techniques that allow a synergetic use of information from satellite and from Chemical Transport Models
(CTM). In fact the in situ sampling method used by the local environmental agencies for air quality monitoring is becoming too
expensive to be further continued without a sensible reduction in the number of observing stations.
In this paper we present the work that has been performed so far within the QUITSAT project funded by the Italian Space Agency.
SCIAMACHY (Uv-Vis spectrometer on board ESA-ENVISAT platform from 2002) observations of earth radiance are used to
retrieve NO2 tropospheric column by DOAS spectrometric technique and radiative transfer modelling for AMF computation. Such
kind of product has been widely used to estimate emissions, to monitor pollution hot spot as well as cross country and
intercontinental transport. Within this work we have merged the column measurements of nitrogen dioxide with the simulations of
the Transport Chemical Aerosol Model (TCAM) to improve the model output at the ground level. The method used is a weighted
rescaling of the model column in the troposphere according to the SCIAMACHY observations where the weights are the
measurement errors and the model column variances within the satellite ground-pixel, respectively. The employed data are related to
the Northern Italy area.
The obtained ground concentrations of NO2 have been compared with in-situ observations performed by the regional environmental
agencies. Results show good agreement mainly where well horizontal mixing is present. The ground concentration from
SCIAMACHY-TCAM gives an average NO2 amount within the satellite ground-pixel of 30x60 km2 that is important information
for air quality assessment on a regional and/or national scale not easy to obtain only with ground-based observations. Our
conclusions thus stress also the actual potential role of satellite observations combined with regional CTM models in the context of
air quality monitoring, mainly in rural area, where the ground-based observations are missing
Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications
BACKGROUND Limited information exists about the epidemiology and outcome of surgical patients at increased risk of postoperative pulmonary complications (PPCs), and how intraoperative ventilation was managed in these patients.
OBJECTIVES To determine the incidence of surgical patients at increased risk of PPCs, and to compare the intraoperative ventilation management and postoperative outcomes with patients at low risk of PPCs.
DESIGN This was a prospective international 1-week observational study using the ‘Assess Respiratory Risk in Surgical Patients in Catalonia risk score’ (ARISCAT score) for PPC for risk stratification.
PATIENTS AND SETTING Adult patients requiring intraoperative ventilation during general anaesthesia for surgery in 146 hospitals across 29 countries.
MAIN OUTCOME MEASURES The primary outcome was the incidence of patients at increased risk of PPCs based on the ARISCAT score. Secondary outcomes included intraoperative ventilatory management and clinical outcomes.
RESULTS A total of 9864 patients fulfilled the inclusion criteria. The incidence of patients at increased risk was 28.4%. The most frequently chosen tidal volume (VT) size was 500 ml, or 7 to 9 ml kg1 predicted body weight, slightly lower in patients at increased risk of PPCs. Levels of positive end-expiratory pressure (PEEP) were slightly higher in patients at increased risk of PPCs, with 14.3% receiving more than 5 cmH2O PEEP compared with 7.6% in patients at low risk of PPCs (P < 0.001). Patients with a predicted preoperative increased risk of PPCs developed PPCs more frequently: 19 versus 7%, relative risk (RR) 3.16 (95% confidence interval 2.76 to 3.61), P < 0.001) and had longer hospital stays. The only ventilatory factor associated with the occurrence of PPCs was the peak pressure.
CONCLUSION The incidence of patients with a predicted increased risk of PPCs is high. A large proportion of patients receive high VT and low PEEP levels. PPCs occur frequently in patients at increased risk, with worse clinical outcome
Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin induced by physical exercise in man.
Giant congenital nevus and chronic progressive ascending hemiparesis (Mills syndrome). Report of a case
A web-based clinical record 'xl'Emofilia' for outpatients with haemophilia and allied disorders in the Region of Emilia-Romagna: features and pilot use.
The treatment of haemophilia in developed countries is based on home self-infusion of concentrates. Improving communication between haemophilia centres (HC) and patients is very important. The Hub Centre (Parma) designed a new outpatient clinical record, 'xl'Emofilia', as part of a project 'Web Connections of the Region's HC' funded by Emilia-Romagna Health Authority. It is a web-based application suited to the needs of HC, which shares the databases of the region's HC, integrated with regional and national registries that can be accessed from anywhere. Data are managed with the 'https' protocol. Significant innovations are 'pathways' that help with the entry of data and 'problem list', which is a summary (updated automatically) of the patient's clinically significant data that can be consulted at a glance. With a 'web identity' (a personal USB key for secure web access), patients can record bleeds and home infusions, consult their own data and allow access to their general practitioners or in emergency departments anywhere in the world (also in English language). In December 2006, the HC started to use 'xl'Emofilia' and 673 clinical records are now active. Since April 2007, 50 pilot patients have been trained and are successfully using the system. A questionnaire administered to these patients on their level of satisfaction with the system and its ease of use gave excellent results. Our web-based system facilitates communication between patients and HC, improves the quality of care and enables patients to use these information at any time and from anywhere in the world
Influência dos resíduos da mineração do xisto no crescimento e no teor foliar de Cd, Co e Cr em plantas de aveia preta
Celiac disease in 87 children with typical and atypical symptoms in Black Sea region of Turkey
Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease
PERTINENT - PERindopril-Thrombosis, InflammatioN, endothelial dysfunction and neurohormonal activation trial: A sub-study of the EUROPA study
BACKGROUND: Markers of thrombosis, inflammation, endothelial dysfunction and neurohumoral activation such as fibrinogen, D-dimer, C-reactive protein, von Willebrand factor, tumour necrosis factor-alpha and chromogranin-A are reported to be linked to the increase of cardiovascular risk for atherosclerosis progression and events in patients with cardiovascular diseases. METHODS: EUROPA is a double blind, placebo-controlled trial on 12,231 patients that evaluates the effect of an angiotensin converting enzyme inhibitor--perindopril--on prevention of cardiovascular events in patients with coronary artery disease. PERTINENT is a sub-study of EUROPA that evaluates (a) in Part A (300 patients): the influence of perindopril vs. placebo on fibrinogen, D-dimer, C-reactive protein, von Willebrand factor, tumour necrosis factor-alpha and chromogranin-A. In addition, NOS expression and induction of apoptosis on human umbilical vein endothelial cells and angiotensin converting enzyme levels are also studied; (b) in Part B (about 1200 patients): the predictive role of plasma levels of C-reactive protein and von Willebrand factor on the occurrence of cardiovascular events. To this end, matched case-control analyses are planned (patients with vs. patients without events). STATUS OF PERTINENT: Blood analyses are in progress in four specialised laboratories: (a) Gaubius Laboratory, Leiden, TNO-PG, The Netherlands; (b) University Department of Medicine, Birmingham, UK; (c) University of Pavia, Italy; (d) Fondazione Salvatore Maugeri, Cardiovascular Research Centre, Gussago, Italy. CONCLUSIONS: The PERTINENT sub-study might help elucidating the phenomena contributing to the pathophysiology of cardiovascular events in patients with coronary artery disease and the role of perindopril in such context